These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 11691825)
1. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Feng G; Xu X; Youssef EM; Lotan R Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825 [TBL] [Abstract][Full Text] [Related]
2. S100A2 induces metastasis in non-small cell lung cancer. Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029 [TBL] [Abstract][Full Text] [Related]
3. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823 [TBL] [Abstract][Full Text] [Related]
5. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641 [TBL] [Abstract][Full Text] [Related]
6. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer. Strazisar M; Rott T; Glavac D Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279 [TBL] [Abstract][Full Text] [Related]
7. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer. Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609 [TBL] [Abstract][Full Text] [Related]
8. S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. Smith SL; Gugger M; Hoban P; Ratschiller D; Watson SG; Field JK; Betticher DC; Heighway J Br J Cancer; 2004 Oct; 91(8):1515-24. PubMed ID: 15467767 [TBL] [Abstract][Full Text] [Related]
9. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer. Wang H; Zhang Z; Li R; Ang KK; Zhang H; Caraway NP; Katz RL; Jiang F Int J Cancer; 2005 Aug; 116(2):285-90. PubMed ID: 15800916 [TBL] [Abstract][Full Text] [Related]
12. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development. Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198 [TBL] [Abstract][Full Text] [Related]
13. Identification of early growth response gene-1 (Egr-1) as a phorbol myristate acetate-induced gene in lung cancer cells by differential mRNA display. You L; Jakowlew SB Am J Respir Cell Mol Biol; 1997 Nov; 17(5):617-24. PubMed ID: 9374113 [TBL] [Abstract][Full Text] [Related]
14. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117 [TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. Tsai WC; Tsai ST; Jin YT; Wu LW Mol Cancer Res; 2006 Aug; 4(8):539-47. PubMed ID: 16908593 [TBL] [Abstract][Full Text] [Related]
16. S100A2, a potential marker for early recurrence in early-stage oral cancer. Tsai ST; Jin YT; Tsai WC; Wang ST; Lin YC; Chang MT; Wu LW Oral Oncol; 2005 Apr; 41(4):349-57. PubMed ID: 15792606 [TBL] [Abstract][Full Text] [Related]
17. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Diederichs S; Bulk E; Steffen B; Ji P; Tickenbrock L; Lang K; Zänker KS; Metzger R; Schneider PM; Gerke V; Thomas M; Berdel WE; Serve H; Müller-Tidow C Cancer Res; 2004 Aug; 64(16):5564-9. PubMed ID: 15313892 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of Betaig-h3 gene in human cancer cells. Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406 [TBL] [Abstract][Full Text] [Related]
20. Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung. Siddiq F; Sarkar FH; Wali A; Pass HI; Lonardo F Lung Cancer; 2004 Aug; 45(2):197-205. PubMed ID: 15246191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]